MedPath
HSA Approval

DEFUZIN-B CREAM

SIN15684P

DEFUZIN-B CREAM

DEFUZIN-B CREAM

May 13, 2019

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D07CC01

betamethasone and antibiotics

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

BETAMETHASONE-17- VALERATE 1.21mg/g EQV BETAMETHASONE (MICRONIZED)

1mg/g

Estradiol valerate

FUSIDIC ACID (MICRONIZED)

20.0mg/g

Fusidic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.